相关实验视频

Updated: Jul 10, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

泛亡:在乳腺癌治疗和预后中为编程细胞死亡的潜在新目标

Xinxin Liu^1,2, Meiqi Miao^2,3, Jijing Sun²

¹School of Basic Medical Sciences, Heilongjiang University of Traditional Chinese Medicine, Harbin, 150040, China.

Apoptosis : an international journal on programmed cell death

|November 24, 2023

概括

一种新型编程细胞死亡的PANoptosis正在被研究,因为它在乳腺癌中的作用. 了解这种细胞死亡机制可能会揭示治疗乳腺癌的新治疗点.

科学领域:

在瘤学瘤学.
细胞生物学细胞生物学
免疫学免疫学免疫学

背景情况:

乳腺癌仍然是一个重大的全球健康挑战,发病率和死亡率不断上升.
编程细胞死亡 (PCD) 越来越多地被认为是它在癌症发展中的作用.
帕诺灭,一种由PANoptosome复合体调节的新发现的细胞死亡途径,整合了烧灭,灭和灭的特征.

研究的目的:

定义PANoptosis及其与其他PCD途径的关系.
研究PANoptosis对乳腺癌发展的影响.
探索目前的研究和未来的方向,以准乳腺癌治疗中的PANoptosis.

主要方法:

文献综述和系统分析关于PANoptosis和乳腺癌的现有研究.
探索导致PANoptosis的分子机制.
讨论针对PANoptosis的潜在治疗策略.

主要成果:

泛光死是一种独特的PCD形式,可能与乳腺癌有关.
PANoptosome复合体是调节这种细胞死亡途径的核心.
有证据表明,PANoptosis可以作为一种防御机制,并影响细胞平衡.

结论:

在乳腺癌的背景下,PANoptosis为编程细胞死亡提供了一个新的视角.
向PANoptosis为开发创新的乳腺癌治疗方法提供了一个有希望的途径.
对PANoptosis信号通路的进一步研究可能会导致有效的多目标组合疗法.

关键词:

细胞灭亡 (apoptosis) 是一种死亡的过程.乳腺癌 (BC) 是一种癌症.尸体灭 (Necroptosis) 是一种死亡的过程.这就是PANoptosis.编程细胞死亡 (PCD)热灭菌的发生.

更多相关视频

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

Published on: January 26, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...